Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Maeve Lowery

1-50 of 68 results

View this query on the Wikidata Query Service
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

scientific article published on 8 May 2017
OncoKB: A Precision Oncology Knowledge Base

scientific article published on 16 May 2017
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.

scientific article published on 28 November 2017
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.

scientific article published in September 2017
An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions

scientific article
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations.

scientific article
Identification of germline genetic mutations in patients with pancreatic cancer

scientific article published on 06 October 2015
FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma

scientific article published on 12 June 2015
Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy.

scientific article published on 31 October 2011
A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma

scientific article published in July 2014
Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma

scientific article
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype

scientific article published on 28 July 2017
Biliary carcinomas: pathology and the role of DNA mismatch repair deficiency.

scientific article
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma

scientific article published on 16 January 2018
Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention

scientific article published on 30 May 2018
Pharmacogenomic modeling of circulating tumor and invasive cells for prediction of chemotherapy response and resistance in pancreatic cancer

scientific article
Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition

article
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms

scientific article published on 01 October 2018
Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches.

scientific article published on 16 February 2016
Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

scientific article published on 01 August 2017
DNA mismatch repair abnormalities in acinar cell carcinoma of the pancreas: frequency and clinical significance

scientific article published on 01 November 2014
Treatment, Outcomes, and Clinical Trial Participation in Elderly Patients With Metastatic Pancreas Adenocarcinoma

scientific article published on 22 May 2015
A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma.

scientific article
Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients.

scientific article published on 7 December 2017
Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications.

scientific article published on 7 May 2016
Current management and future directions in metastatic pancreatic adenocarcinoma.

scientific article published on 20 September 2016
A Combination of Radiation and the Hypoxia-Activated Prodrug Evofosfamide (TH-302) is Efficacious against a Human Orthotopic Pancreatic Tumor Model.

scientific article published on 21 July 2017
Genomics and pharmacogenomics of pancreatic adenocarcinoma

scientific article published on December 20, 2011
Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer.

scientific article published on 29 June 2017
Postresection surveillance for pancreatic cancer performance status, imaging, and serum markers.

scientific article
A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression

scientific article published on 18 July 2014
Novel Therapeutics for Pancreatic Adenocarcinoma

scientific article published on August 2015
A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma

scientific article published on 01 September 2011
Systemic therapy for biliary cancers.

scientific article published on October 2016
In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer Models.

scientific article published on 27 March 2017
Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models.

scientific article
Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference

scientific article published on December 2016
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial

scientific article published on 31 October 2019
Pancreatic cancer: the role of molecular markers in diagnosis and management

scientific article published on December 1, 2011
Clinical pharmacokinetics and pharmacodynamics of ivosidenib, an oral, targeted inhibitor of mutant IDH1, in patients with advanced solid tumors

scientific article published on 26 April 2019
Incidence, Management, and Implications of Visceral Thrombosis in Pancreatic Ductal Adenocarcinoma.

scientific article published on 31 January 2018
(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies

scientific article
Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma.

scientific article published in January 2018
Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes

scientific article published on 27 August 2019
Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma

article
Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes

scientific article published on 08 January 2019
Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma

scientific article published on 12 July 2019
New approaches to the treatment of pancreatic cancer: from tumor-directed therapy to immunotherapy

scientific article published on 01 August 2011
Case report: primary acinar cell carcinoma of the liver treated with multimodality therapy

scientific article published in October 2017
Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes

scientific article published on 12 February 2017

Paulina is supported by:

About Paulina

Help